Covista Inc. CVSA R2KR3K
Company Overview
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. has a strategic collaboration agreement with Advocate Health to expand access to nursing education and build a direct pipeline of practice-ready nurses across the communities Advocate Health serves. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
Why Investors Should Care
Generates a return on equity of 17.9%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 15.2%.
Trades at a P/E of 18.6, below the sector median of 18.7.
Operating margin of 18.9% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Jun 2026 Revenue of $1.95B (+9.3% YoY); net profit $251.57M.
- Trailing 12 Months Year-on-year growth — revenue +4.5%, earnings -24.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 1.3%, profit CAGR 2.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 1.27% |
| 1 Year: | 4.50% |
Compounded Profit Growth
| 5 Years: | 2.27% |
| 1 Year: | -24.60% |
Stock Price Performance
| 1 Year: | -0.85% |
| 6 Months: | +25.52% |
| 3 Months: | +1.14% |
| 1 Month: | +3.08% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)46.51 · Neutral
P/E of 18.64 is below the sector median of 18.74 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CVSA Covista Inc. R2KR3K | 128.09 | 18.64 | $4.36B | 0.00% | 15.22% | 17.85% | 1.27% | 2.27% |
| 2 | WMT Walmart Inc. SPXR3K | 107.14 | 37.73 | $852.63B | 0.88% | 16.83% | 24.13% | 3.82% | 3.24% |
| 3 | COST Costco Wholesale Corporation NDXSPXR3K | 915.74 | 46.16 | $406.11B | 0.62% | 25.96% | 29.15% | 8.16% | 11.45% |
| 4 | KO The Coca-Cola Company SPXR3K | 88.07 | 26.45 | $378.93B | 2.44% | 16.47% | 42.05% | 2.86% | 4.46% |
| 5 | PG The Procter & Gamble Company SPXR3K | 146.44 | 22.32 | $341.00B | 2.96% | 22.49% | 30.29% | 0.52% | 1.59% |
| 6 | PM Philip Morris International Inc. SPXR3K | 182.53 | 25.07 | $284.49B | 3.13% | 34.03% | -113.55% | -1.69% | 3.57% |
| 7 | PEP PepsiCo, Inc. NDXSPXR3K | 137.63 | 18.04 | $188.00B | 4.28% | 15.41% | 51.51% | 4.93% | 2.11% |
| 8 | BUD Anheuser-Busch InBev SA/NV | 80.35 | 17.32 | $140.40B | 1.61% | 8.49% | 11.39% | 0.88% | 4.63% |
| 9 | MO Altria Group, Inc. SPXR3K | 68.88 | 14.50 | $115.01B | 6.26% | 38.27% | - | 1.24% | -1.89% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 292.04M | 301.51M | 299.14M | 315.22M | 293.14M | 308.21M | 310.07M | 319.79M | 236.94M | 253.96M | 258.70M | 264.24M | 254.61M | 266.17M | 271.49M | 259.73M | 218.83M | 234.40M | 230.21M | 223.47M | 289.07M | 371.20M | 364.28M | 361.23M | 354.27M | 362.83M | 369.08M | 368.85M | 393.24M | 412.66M | 417.40M | 447.73M | 466.06M | 457.11M | 462.29M | 503.38M | 487.03M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 199.87M | 198.93M | 200.77M | 205.43M | 210.72M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 266.19M | 258.18M | 261.52M | 297.96M | 276.31M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 175.17M | 180.86M | 175.73M | 182.79M | 184.11M |
| Operating Income | -56.38M | 60.85M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 25.95M | 29.06M | 35.96M | 27.08M | -22.06M | 24.73M | 32.95M | 44.53M | 23.63M | 45.55M | 59.43M | 28.19M | 58.61M | 61.73M | 70.24M | 103.87M | 91.02M | 77.31M | 85.79M | 115.17M | 92.20M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 115.02M | 98.33M | 106.71M | 132.47M | 110.80M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.37M | 9.30M | 9.52M | 9.62M | 12.08M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 79.33M | 68.58M | 76.87M | 101.90M | 77.94M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 18.54M | 14.12M | 15.81M | 25.73M | 19.96M |
| Net Income | -50.59M | 51.92M | -9.97M | 25.15M | 14.41M | 39.86M | 42.86M | 12.79M | -81.16M | 39.33M | 62.81M | -9.53M | 17.30M | 37.91M | 49.50M | 14.36M | 5.53M | 150.83M | -256.05M | 19.93M | 23.32M | 24.65M | 9.01M | -58.00M | 17.85M | 347.74M | 8.01M | 592.00K | 24.65M | 45.87M | 10.65M | 39.89M | 36.82M | 46.16M | 75.86M | 60.83M | 54.21M | 61.83M | 76.38M | 41.64M |
| Diluted EPS | -0.79 | 0.81 | -0.16 | 0.39 | 0.23 | 0.62 | 0.67 | 0.20 | -1.33 | 0.63 | 1.02 | -0.16 | 0.29 | 0.64 | 0.86 | 0.26 | 0.10 | 2.83 | -4.86 | 0.38 | 0.44 | 0.48 | 0.18 | -1.17 | 0.36 | 7.04 | 0.18 | 0.01 | 0.53 | 1.00 | 0.25 | 0.98 | 0.93 | 1.18 | 1.98 | 1.59 | 1.44 | 1.67 | 2.11 | 1.20 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.46B | 1.92B | 269.04M | 350.50M | 415.40M | 465.94M | 1.91B | 1.08B | 1.21B | 960.28M | 1.01B | 866.43M | 899.25M | 1.38B | 1.45B | 1.58B | 1.79B | 1.95B |
| Operating Income | 234.83M | 410.90M | 501.51M | 238.93M | 166.93M | 181.27M | 156.91M | - | - | - | 155.83M | 110.07M | 110.40M | 76.75M | 168.17M | 217.05M | 341.54M | 383.38M |
| Net Income | 165.61M | 279.91M | 330.40M | 141.56M | 106.79M | 134.03M | 139.90M | -3.17M | 122.28M | 33.77M | 95.17M | -85.33M | 70.03M | 310.99M | 93.36M | 136.78M | 237.06M | 251.57M |
| Diluted EPS | 2.28 | 3.87 | 4.68 | 2.09 | 1.65 | 2.07 | 2.14 | -0.05 | 1.91 | 0.54 | 1.60 | -1.58 | 1.36 | 6.43 | 2.05 | 3.39 | 6.18 | 7.04 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2008 | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 1.63B | 1.85B | 1.84B | 1.86B | 2.00B | 2.04B | 2.10B | 2.32B | 2.34B | 2.24B | 2.26B | - | 3.03B | - | 2.84B | - | 2.81B | - | 2.74B | 2.75B | 3.01B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 557.10M | - | - | - | 480.30M | - | 418.08M | 416.19M | - |
| Cash & Equivalents | 217.20M | 165.20M | 307.70M | 447.05M | 173.98M | 196.58M | 358.19M | 353.02M | 308.16M | 240.43M | 430.69M | 204.20M | 500.52M | - | 346.97M | 325.83M | 206.28M | 313.76M | 272.19M | 260.83M | 219.31M | 199.60M | 406.32M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 81.64M | - | - | - | 102.75M | - | 126.83M | 146.19M | - |
| Total Liabilities | - | - | 443.44M | 454.23M | 477.90M | 459.01M | 457.85M | 445.40M | 509.80M | 639.69M | 816.57M | 841.62M | 915.41M | - | 1.54B | - | 1.33B | - | 1.35B | - | 1.37B | 1.32B | 1.57B |
| Current Liabilities | - | - | 343.85M | 316.43M | 314.88M | 316.22M | 316.81M | 321.91M | 361.84M | 377.33M | 365.78M | 311.63M | 345.98M | - | 423.65M | - | 376.64M | - | 431.20M | - | 487.66M | 507.93M | 596.82M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | 125.00M | 290.07M | 398.09M | 286.12M | - | 838.91M | - | - | - | 695.08M | - | 648.71M | 552.67M | 657.75M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07B | - | - | - | 896.19M | - | 847.85M | 774.00M | - |
| Total Equity | 766.43M | 926.94M | 1.18B | 1.39B | 1.36B | 1.40B | 1.53B | 1.58B | 1.58B | 1.67B | 1.52B | 1.39B | 1.31B | - | 1.49B | - | 1.51B | - | 1.46B | - | 1.37B | 1.43B | 1.45B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 81.80M | - | - | - | 82.23M | - | 83.19M | 83.94M | - |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 249.56M | 391.55M | 407.99M | 277.42M | 261.50M | 265.56M | 205.50M | 231.48M | 230.92M | 239.19M | 204.86M | 107.69M | 192.20M | 10.60M | 191.91M | 295.77M | 337.90M | 470.42M |
| Investing Cash Flow | -389.43M | -85.79M | -125.99M | -380.01M | -152.63M | -84.33M | -155.88M | -215.41M | -379.65M | -71.45M | -213.84M | 382.52M | -56.69M | -551.80M | 23.74M | -47.85M | -41.92M | -83.70M |
| Financing Cash Flow | 86.17M | -161.84M | -140.19M | -168.02M | -82.56M | -19.14M | -48.61M | -69.09M | 85.84M | 37.20M | -137.53M | -256.11M | 676.47M | -424.48M | -288.51M | -301.80M | -316.02M | -180.13M |
| Capital Expenditure | - | - | - | - | - | -79.36M | -88.71M | -51.45M | -42.51M | -46.62M | -57.57M | -39.60M | -39.88M | -31.05M | -26.01M | -48.89M | -50.33M | -77.70M |
| Free Cash Flow | - | - | - | - | - | 186.21M | 116.80M | 180.03M | 188.41M | 192.57M | 147.28M | 68.09M | 152.32M | -20.45M | 165.90M | 246.88M | 287.57M | 392.73M |
| Share Buybacks | 33.68M | 41.68M | 132.94M | 158.09M | 53.89M | 0 | 25.92M | 32.63M | 48.51M | 137.03M | 252.85M | 136.89M | 100.00M | 120.00M | 123.13M | 261.97M | 213.12M | 239.87M |
Ratios (Annual)
Figures in %.
| Metric | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 16.1% | 21.5% | 186.4% | 68.2% | 40.2% | 38.9% | 8.2% | - | - | - | 15.4% | 12.7% | 12.3% | 5.6% | 11.6% | 13.7% | 19.1% | 19.6% |
| Net Margin % | 11.3% | 14.6% | 122.8% | 40.4% | 25.7% | 28.8% | 7.3% | -0.3% | 10.1% | 3.5% | 9.4% | -9.8% | 7.8% | 22.5% | 6.4% | 8.6% | 13.3% | 12.9% |
| ROE % | 17.9% | 23.7% | 23.8% | 10.4% | 7.6% | 8.7% | 8.8% | -0.2% | 7.3% | 2.2% | 6.8% | -6.5% | - | 20.9% | 6.4% | 10.0% | 16.5% | 17.4% |
| ROCE % | - | 32.0% | 32.7% | 15.6% | 10.8% | 10.8% | 9.1% | - | - | - | 8.1% | 5.8% | - | 2.9% | 7.1% | 9.6% | 15.2% | 15.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 16.10% | 5.48M | $736.94M |
| 2 | FMR, LLC | 9.45% | 3.22M | $432.75M |
| 3 | Vanguard Portfolio Management LLC | 7.01% | 2.39M | $320.97M |
| 4 | Dimensional Fund Advisors LP | 5.24% | 1.78M | $239.73M |
| 5 | Ariel Investments, LLC | 5.21% | 1.77M | $238.26M |
| 6 | Vanguard Capital Management LLC | 4.33% | 1.47M | $198.20M |
| 7 | State Street Corporation | 4.08% | 1.39M | $186.84M |
| 8 | Capital World Investors | 3.12% | 1.06M | $143.03M |
| 9 | Geode Capital Management, LLC | 2.63% | 894.26K | $120.25M |
| 10 | Wellington Management Group, LLP | 2.36% | 802.05K | $107.85M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CVSA
Covista (CVSA) Could Be 20% Undervalued As Workforce Shortages Support Its Growth Story - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNSDRRVWJtazBVZmxyWjQ1OVhIX1RzdDVqZVdUME5oVFFpWTdGV2g4dWVIS1hReXhCSGpLQV90bm94aHR4NkdjbG5Kdl8tRlRiMzRNTE5IS3JlSzFIUENEcUhrSXVyZ0Q0RmNPRVRRRVFaVFdINHJ4YmsyUGRsblhXMkQ3TGFJWWRENXVUOT…
Adtalem Global Education (NYSE:CVSA) Shares Gap Down After Analyst Downgrade - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxOSW9TTlRKSjFuRDRUZW85MXoxam9GaGp4MTNjZXpRSFBodHNJWkEtdnRxTDJvMWxhc211cUdsZ1hhZndyb3NLUFV4Um5xdWhyb1pJbEJ3cGVROHQyVG92bnAtVEtkcGdUSjhYNzUxY1NGYWNGN0hQb21yMnZ0UE5OcmxXYTh0NmVCeU1YMG…
Covista Inc (CVSA) Shares Fall 4.9% -- GF Value Says Still Overv - GuruFocus
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOWERQTV9nNXMzWkJ0eVhxbXd6THJVNU15Snc1d2duQXplYURpNWIwUy0zVUc0RC0ydlRWaV9qUFZnUF9HdHIxRnluREgyaFA5dHlOdUJGR19CSW9Gb2lQcXhUUFBLb093bVRYQmVMaGwzRE1GQnFsU2JsYUxuRnU0S1Jld0VNSklIVWU4d0…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFBLVkhIUEpmTEk3czFvNTdFNmgtblJ3RGtaVU5JOTU4RkNrTVYxQmc3WGc2LWlkSXZCcWpWMUZGMldBRl9qMlFFSHlVbml5UDN1?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Covista (CVSA) Stock Trades Up, Here Is Why - StockStory
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxObFdLZmNxdDdQMk8tQl9qT1labTUzR3FNR0FZekxuQVRCc3Z5RlVxSjB1dkpRdmt1MWlRWXZ1RVFQT3VuM3M2TG51eFpFV3dpeEpnd1hKR2xUc3l6V2xFWUx3ckc3OXFKdk8zdGpzSms5YWkwNGd3ZDBxbnNiUVdGdk9iUWZDNDFxRXpRVC…
Covista Inc. (CVSA) legal chief gets 4,242 and 6,060-share awards - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxON2k3WV9peWpRbTlHU3gzb1ZlT21RZGM2dVVlR0lZakw1WXJNZjB1aktHemtIMDQ4ZU15bEcyYlVMeFlSbmRzLURxTXp1cngzc01wUDdNRmFmZUkyWHBqbkpOMGM5bTExVlM3eHBtS19kLXYyam51WUtMcV9XSEF6TlcwaWFBVXp6Vlpjbn…
CVSA — Frequently Asked Questions
What is the current share price of Covista Inc. (CVSA)?
As of 2026-09-07 16:24 PDT, Covista Inc. (CVSA) trades at $128.09 on NYSE. Its 52-week range is $89.36 to $154.45.
What is the market capitalisation of CVSA?
Covista Inc. (CVSA) has a market capitalisation of $4.36B on NYSE.
What is the P/E ratio of CVSA?
CVSA trades at a trailing price-to-earnings (P/E) ratio of 18.64. The industry average P/E is 18.74. Its price-to-book (P/B) ratio is 3.52.
What is the return on equity (ROE) of CVSA?
CVSA has a return on equity (ROE) of 17.85%. Its return on capital employed (ROCE) is 15.22%.
Is CVSA a good stock to buy?
This page provides a data-driven analysis of Covista Inc. (CVSA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.